Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery ~13 mi. (Anderson, Indiana, +387 more cities) Saint Vincent Anderson Regional Hospital/Cancer Center ERBB2 Amplification Breast Carcinoma radiation therapy radiation therapy
Chemotherapy and Atezolizumab for Patients With Extensive Stage Small Cell Lung Cancer (SCLC) With Untreated, Asymptomatic Brain Metastases ~13 mi. (Anderson, Indiana, +5 more cities) St. Vincent Anderson Regional Hospital Small Cell Lung Carcinoma atezolizumab, +2 more drugs chemotherapy, +1 more type
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer ~28 mi. (Muncie, Indiana, +269 more cities) IU Health Ball Memorial Hospital ER Positive, +1 more biomarker Invasive Breast Carcinoma radiation therapy, +1 more drug radiation therapy
Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung Cancer ~28 mi. (Muncie, Indiana, +469 more cities) IU Health Ball Memorial Hospital Non-Small Cell Lung Carcinoma carboplatin, +6 more drugs chemotherapy, +2 more types
A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing Tumors ~28 mi. (Muncie, Indiana, +117 more cities) Research Site ERBB2 Amplification, +1 more biomarker Biliary Tract Carcinoma, +6 more conditions fam-trastuzumab deruxtecan targeted therapy
A Study of T-DXd for the Treatment of Solid Tumors Harboring HER2 Activating Mutations ~28 mi. (Muncie, Indiana, +35 more cities) Research Site ERBB2 Codon 755 Missense, +18 more biomarkers Adenocarcinoma of the Gastroesophageal Junction, +3 more conditions fam-trastuzumab deruxtecan targeted therapy
Radiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast Cancer ~30 mi. (Fishers, Indiana, +145 more cities) IU Health Central Indiana Cancer Centers-Fishers Inflammatory Breast Carcinoma olaparib, +1 more drug radiation therapy, +1 more type
T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial ~33 mi. (Carmel, Indiana, +576 more cities) IU Health North Hospital ERBB2 Amplification, +1 more biomarker Breast Carcinoma ado-trastuzumab emtansine, +1 more drug targeted therapy
Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy ~33 mi. (Carmel, Indiana, +744 more cities) IU Health North Hospital Breast Carcinoma axillary lymph node dissection, +1 more drug radiation therapy, +1 more type
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial ~33 mi. (Carmel, Indiana, +327 more cities) IU Health North Hospital Multiple Myeloma bortezomib, +3 more drugs chemotherapy, +3 more types
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair ~33 mi. (Carmel, Indiana, +656 more cities) IU Health North Hospital Deficient DNA Mismatch Repair (dMMR), +8 more biomarkers Colon Adenocarcinoma, +1 more condition atezolizumab, +3 more drugs chemotherapy, +1 more type
CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy ~33 mi. (Carmel, Indiana, +533 more cities) IU Health North Hospital ERBB2 Amplification, +1 more biomarker Invasive Breast Carcinoma ado-trastuzumab emtansine, +6 more drugs chemotherapy, +2 more types